- Previous Close
28.50 - Open
29.00 - Bid 27.00 x --
- Ask 28.00 x --
- Day's Range
27.12 - 29.00 - 52 Week Range
15.20 - 30.00 - Volume
435,382 - Avg. Volume
147,264 - Market Cap (intraday)
63.312M - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.06 - Earnings Date Jun 26, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
40.00
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; whey powder and plant-based protein powders; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; and international retailers and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
www.scienceinsport.com330
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SIS.L
View MorePerformance Overview: SIS.L
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SIS.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SIS.L
View MoreValuation Measures
Market Cap
65.61M
Enterprise Value
77.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.92
Price/Book (mrq)
2.47
Enterprise Value/Revenue
1.43
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-19.45%
Return on Assets (ttm)
-8.01%
Return on Equity (ttm)
-32.89%
Revenue (ttm)
53.94M
Net Income Avi to Common (ttm)
-10.49M
Diluted EPS (ttm)
-0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
1.53M
Total Debt/Equity (mrq)
49.24%
Levered Free Cash Flow (ttm)
4.44M